Načítá se...
The Economics of Reproducibility in Preclinical Research
Low reproducibility rates within life science research undermine cumulative knowledge production and contribute to both delays and costs of therapeutic drug development. An analysis of past studies indicates that the cumulative (total) prevalence of irreproducible preclinical research exceeds 50%, r...
Uloženo v:
| Vydáno v: | PLoS Biol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Public Library of Science
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4461318/ https://ncbi.nlm.nih.gov/pubmed/26057340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pbio.1002165 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|